Pregnancy-Related Hypertension: Adherence to a New Type of Monitoring
Last updated on July 2021Recruitment
- Recruitment Status
- Enrolling by invitation
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Chronic Hypertension With Pre-Eclampsia Complicating Childbirth (Diagnosis)
- Gestational Hypertension
- HELLP Syndrome
- Preeclampsia
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Control arm: will be scheduled an in-office blood pressure check 7-10 days postpartum Intervention arm: will receive a blood pressure cuff and app with which to monitor their blood pressures at home for 16 days postpartumMasking: None (Open Label)Primary Purpose: Health Services Research
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Only males
Description
While inpatient during the postpartum period, patients will be identified who were diagnosed with hypertensive disorders of pregnancy antepartum, intrapartum, or postpartum. These patients will be recruited prior to discharge home. This will be a randomized control trial, non-blinded. The study grou...
While inpatient during the postpartum period, patients will be identified who were diagnosed with hypertensive disorders of pregnancy antepartum, intrapartum, or postpartum. These patients will be recruited prior to discharge home. This will be a randomized control trial, non-blinded. The study group will receive a mobile app for postpartum education and an integrated Wi-Fi connected blood pressure cuff for at-home monitoring for 16 days postpartum. The home BP monitoring will occur twice a day and study team will check the BPs twice a day and intervene by phone or text if necessary. The control group will be scheduled for blood pressure checks at the clinic between days 7-10. These groups will be compared with regard to identification of severe blood pressures (>/= 160/100), adherence to ACOG guidelines for blood pressure monitoring, timing of the identification and treatment of severe blood pressures, readmissions, and patient satisfaction.
Tracking Information
- NCT #
- NCT04823949
- Collaborators
- Medical University of South Carolina
- South Carolina Telehealth Alliance
- Babyscripts
- Investigators
- Principal Investigator: Renata Sawyer, MD Prisma Health-Upstate Principal Investigator: David Soper, MD Medical University of South Carolina